CGON
CG Oncology, Inc. Common stock
NASDAQ · USHealthcareBiotechnology
$70.19-2.31%
Price as of Jul 20, 2026
CGON profitability
CG Oncology, Inc. Common stock profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- -664.8%
- EBITDA margin
- -3638.0%
- EBIT margin
- -4239.0%
- Net margin
- -3682.6%
- Free cash flow margin
- -3163.8%
Returns
- Return on equity
- -17.1%
- Return on assets
- -16.4%
- Return on invested capital
- -19.6%
- Asset turnover
- 0.01x
Cash efficiency
- Cash from operations
- -$160.0M
- Cash per share
- $12
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.